Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-20
2009-02-24
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S184000
Reexamination Certificate
active
07495012
ABSTRACT:
Arylsulfonamide compounds of formula I are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders:
REFERENCES:
patent: WO 97/49695 (1997-12-01), None
patent: WO 98/53814 (1998-12-01), None
patent: WO 01/02375 (2001-01-01), None
patent: WO 01/77101 (2001-10-01), None
patent: WO 01/90090 (2001-11-01), None
patent: WO 01/90091 (2001-11-01), None
patent: WO 01/90092 (2001-11-01), None
patent: WO 03/002534 (2003-01-01), None
patent: WO 03/037890 (2003-05-01), None
patent: WO 03/044009 (2003-05-01), None
patent: WO 03/057225 (2003-07-01), None
patent: WO 2004/011410 (2004-02-01), None
patent: WO 2004/022561 (2004-03-01), None
patent: WO 2004/092164 (2004-10-01), None
patent: WO 2005/014589 (2005-02-01), None
Vippagunta et al. Advanced Drug Delivery Reviews, 2001, 48, 3-26.
Jantzen and Robinson, Modern Pharmaceutics, 1996, p. 596.
Carloni et al. Tetrahedron, 1995, 51 (45), p. 12445-452).
Barn, et al., “Parallel Synthesis and Biological Activity of a New Class of High Affinity and Selective δ-Opioid Ligand”, Bioorganic & Medicinal Chemistry, 2001, vol. 9, pp. 2609-2624, XP-002351368.
Habashita, et al., “Preparation of nitrogen-containing heterocylic compounds as CXCR4 regulators”, 2004, XP-002381677.
Ito, et al., “Preparation of (pyridylalkyl)amine derivatives as thromboxane A2 antagonists and thromboxane A2 synthetase inhibitors”, 1994, XP-002381676.
Souers, et al., “Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 3”, Bioorganic & Medicinal Chemistry Letters, 2004, vol. 14, pp. 4883-4886, XP-002351369.
Watabe, et al., “Preparation of (piperidinylalkoxy- or pyrrolidinylalkoxy)benzoic acid derivatives as hypolipemic agents”, 1992, XP-002381675.
DeGraffenreid Michael R.
Powers Jay P.
Sun Daqing
Yan Xuelei
Amgen Inc.
Foley & Lardner LLP
Jarrell Noble
Wilson James O.
LandOfFree
Arylsulfonamides and uses related thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfonamides and uses related thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamides and uses related thereto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4113985